IP Library Granted Patent US 8,617,575
Granted Patent B2
US 8,617,575 · App. 11/597,879 · Granted Dec 31, 2013

Methods for conferring immunity against protozoans in an animal

Inventors: Akira Ito (Kitamoto, JP); Toru Gotanda (Kitamoto, JP); Shigeki Kobayashi (Kitamoto, JP); Katsumi Kume (Kitamoto, JP); Takeshi Matsumura (Sapporo, JP)
Assignees: Kitasato Daiichi Sankyo Vaccine Co., Ltd.; National Institute of Advanced Industrial Science and Technology
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,617,575
App. No.
11/597,879
Granted
Dec 31, 2013
Kind
B2
Abstract

Immunity against protozoan is conferred on an animal by a method comprising orally administering to an animal a transformed plant cell comprising a polynucleotide encoding a protective antigen against protozoiasis development, a transformed plant or its progeny or clone comprising the transformed cell, a propagation material of the plant or its progeny or clone, a processed material or extract of the above cell, plant, or its progeny or clone, or propagation material, or a protective antigen against protozoiasis development isolated from the transformed plant cell or the transformed plant or its progeny or clone.

Claims (36)

1. A method for conferring immunity against the development of leucocytozoonosis in an animal comprising orally administering to said animal:

(a) a transformed plant cell comprising a polynucleotide encoding a protective antigen against leucocytozoonosis development, wherein said protective antigen is expressed in said plant cell and wherein said polynucleotide comprises a nucleotide sequence encoding a protein comprising the amino acid sequence of SEQ ID NO: 1 or said polynucleotide comprises the nucleotide sequence of SEQ ID NO: 2;

(b) a transformed plant comprising said transformed plant cell;

(c) a progeny or clone of said transformed plant, wherein said progeny or clone comprises said polynucleotide; or

(d) propagation material of said transformed plant or progeny or clone of said transformed plant; wherein said propagation material comprises the polynucleotide encoding said protective antigen; and

wherein said administration of said plant cell, plant, progeny, clone, or propagation material comprising said protective antigen is in a dose sufficient to result in an increased serum antibody titer of antibodies against said protective antigen.

2. The method of claim 1 , wherein said transformed plant cell comprising a polynucleotide encoding a protective antigen against leucocytozoonosis development is administered to said animal.

3. The method of claim 1 , wherein said transformed plant comprising said transformed plant cell is administered to said animal.

4. The method of claim 1 , wherein said progeny or clone of said transformed plant is administered to said animal.

5. The method of claim 1 , wherein said propagation material of said transformed plant or progeny or clone of said transformed plant is administered to said animal.

6. The method of claim 1 , wherein the progeny or clone of said transformed plant, or propagation material of said transformed plant is administered to said animal.

7. The method of claim 6 , wherein said propagation material is selected from the group consisting of seeds, fruits, grafts, tubers, tubercles, stubbles, calli, and protoplasts.

8. The method of claim 1 , wherein said animal is a bird.

9. The method of claim 8 , wherein said bird is a chicken.

10. The method of claim 1 , wherein said transformed plant is freeze-dried.

11. A method for conferring immunity against the development of leucocytozoonosis in an animal comprising orally administering to said animal:

(a) a transformed plant cell comprising a polynucleotide encoding a protective antigen against leucocytozoonosis development, wherein said protective antigen is expressed in said plant cell and wherein said polynucleotide comprises a nucleotide sequence encoding a protein comprising the amino acid sequence of SEQ ID NO: 1;

(b) a transformed plant comprising said transformed plant cell;

(c) a progeny or clone of said transformed plant, wherein said progeny or clone comprises said polynucleotide; or

(d) propagation material of said transformed plant or progeny or clone of said transformed plant, wherein said propagation material comprises the polynucleotide encoding said protective antigen; and

wherein said administration of said plant cell, plant, progeny, clone, or propagation material comprising said protective antigen supplies said protective antigen in a dose sufficient to result in an increased serum antibody titer of antibodies against said protective antigen.

12. A method for conferring immunity against the development of leucocytozoonosis in an animal comprising orally administering to said animal:

(a) a transformed plant cell comprising a polynucleotide encoding a protective antigen against leucocytozoonosis development, wherein said protective antigen is expressed in said plant cell and wherein said polynucleotide encoding a protective antigen against leucocytozoonosis development comprises the nucleotide sequence of SEQ ID NO: 2;

(b) a transformed plant comprising said transformed plant cell;

(c) a progeny or clone of said transformed plant, wherein said progeny or clone comprises said polynucleotide; or

(d) propagation material of said transformed plant or progeny or clone of said transformed plant, wherein said propagation material comprises the polynucleotide encoding said protective antigen and

wherein said administration of said plant cell, plant, progeny, clone, or propagation material comprising said protective antigen supplies said protective antigen in a dose sufficient to result in an increased serum antibody titer of antibodies against said protective antigen.

13. A method for conferring immunity against the development of leucocytozoonosis in an animal comprising orally administering to said animal a protective antigen against leucocytozoonosis development isolated from the transformed plant cell or the transformed plant or its progeny or clone, and administration of said protective antigen is in a dose sufficient to result in an increased serum antibody titer of antibodies against said protective antigen,

wherein said plant cell, plant, progeny, clone, or propagation material comprising said protective antigen comprises a polynucleotide comprises a nucleotide sequence encoding a protein comprising the amino acid sequence of SEQ ID NO: 1 or said polynucleotide comprises the nucleotide sequence of SEQ ID NO: 2.

14. A method for conferring immunity against the development of leucocytozoonosis in an animal comprising orally administering to said animal:

(a) a transformed plant cell comprising a polynucleotide encoding a protective antigen against leucocytozoonosis development, wherein said protective antigen is expressed in said plant cell and wherein said polynucleotide comprises a nucleotide sequence encoding a protein comprising the amino acid sequence of SEQ ID NO: 1 or said polynucleotide comprises the nucleotide sequence of SEQ ID NO: 2;

(b) a transformed plant comprising said transformed plant cell;

(c) a progeny or clone of said transformed plant, wherein progeny or clone comprises said polynucleotide; or

(d) propagation material of said transformed plant or progeny or clone of said transformed plant; wherein said propagation material comprises the polynucleotide encoding said protective antigen;

wherein said administration of said plant cell, plant, progeny, clone, or propagation material comprising said protective antigen is in a dose sufficient to result in an increased serum antibody titer of antibodies against said protective antigen and

wherein said plant is an edible plant.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 9, 2016
From: KITASATO DAIICHI SANKYO VACCINE CO., LTD.
To: HOKUSAN CO. LTD.
Reel/Frame 037928/0090 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 12, 2012
From: THE KITASATO INSTITUTE
To: KITASATO DAIICHI SANKYO VACCINE CO., LTD.
Reel/Frame 028036/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 15, 2008
From: THE KITASATO INSTITUTE
To: THE KITASATO INSTITUTE
Reel/Frame 021979/0789 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 8, 2007
From: ITO, AKIRA; GOTANDA, TORU; KOBAYASHI, SHIGEKI; KUME, KATSUMI; MATSUMURA, TAKESHI
To: THE KITASATO INSTITUTE; NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY
Reel/Frame 019012/0925 →
Priority Claims (1)
JP 2004-160666 · May 31, 2004 · national
Continuity (1)
Related Publication 20080003243A1 · Jan 3, 2008